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Abstract
O -GlcNAc glycosylation is a dynamic protein posttranslational modification with roles in
processes such as transcription, cell cycle regulation, and metabolism. Detailed mechanistic
studies of O-GlcNAc have been hindered by a lack of methods for measuring O-GlcNAc
stoichiometries and the interplay of glycosylation with other posttranslational modifications. We
recently developed a method for labeling O-GlcNAc-modified proteins with resolvable
poly(ethylene glycol) mass tags. This mass tagging approach enables the direct measurement of
glycosylation stoichiometries and the visualization of distinct O-GlcNAc-modified
subpopulations. Here, we describe protocols for labeling O-GlcNAc glycoproteins in cell lysates
with mass tags.
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Introduction
O-GlcNAc glycosylation (or O-GlcNAcylation) is the posttranslational modification of
serine and threonine residues of proteins with β-linked N-acetyl D-glucosamine. The O-
GlcNAc modification is found on over 500 intracellular proteins and affects processes such
as transcription, apoptosis, glucose sensing, and metabolism (Hart et al., 2007; Love and
Hanover, 2005; Rexach et al., 2008). Chemoenzymatic labeling of O-GlcNAcylated proteins
with a resolvable mass tag is a method for quantitatively imaging and analyzing O-GlcNAc-
modified protein subpopulations. This approach relies on attaching a poly(ethylene glycol)
(PEG) polymer of defined molecular mass (e.g., 2-kDa or 5-kDa) selectively onto the O-
GlcNAc sugar and resolving the labeled populations by SDS-PAGE. The method is
performed in three steps: (1) enzymatic labeling of O-GlcNAc residues with a mutant
galactosyltransferase and an unnatural ketogalactose sugar, (2) conjugation of an aminooxy-
functionalized PEG mass tag to the ketogalactose sugar, (3) SDS-PAGE and
immunoblotting for the protein(s) of interest (Scheme 1a) (Rexach et al., 2010). A variation
on this approach replaces the ketogalactose sugar with an azidogalactose sugar and utilizes
[3+2] azide-alkyne cycloaddition chemistry to conjugate an alkyne-functionalized PEG mass
tag to the glycoproteins (Scheme 1b) (Clark et al., 2008). Notably, this mass tagging
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approach can be applied to endogenous proteins using standard molecular biology
techniques and requires no protein purification, radiolabels, or advanced instrumentation.
The ability to visualize distinct O-GlcNAc-modified subpopulations and quantify in vivo
glycosylation stoichiometries (Fig. 1) provides information that is not readily attainable
using other methods (Rexach et al., 2012; Rexach et al., 2010; Yi et al., 2012). O-GlcNAc
glycosylation stoichiometries can be rapidly measured on endogenous proteins and
compared across different cellular conditions (Rexach et al., 2012; Rexach et al., 2010; Yi et
al., 2012). For example, the mass tagging approach was used to measure changes in the
glycosylation stoichiometry of cyclic-AMP response element-binding protein (CREB) and
phosphofructokinase-1 (PFK1) in response to neuronal depolarization and hypoxia,
respectively (Rexach et al., 2012; Yi et al., 2012). Additionally, the glycosylation state (e.g.,
mono-, di-, or tri-) of proteins can be rapidly established. A protein that exists in a non-
glycosylated, monoglycosylated, and diglycosylated state will resolve into three distinct
bands after mass tagging and SDS-PAGE. When used in conjunction with site-directed
mutagenesis, the approach can also determine the occupancy of the O-GlcNAc sugar at
specific amino acid sites (Rexach et al., 2012; Rexach et al., 2010; Yi et al., 2012). Finally,
the mass tagging approach can be used to monitor the interplay between O-GlcNAcylation
and other post-translational modifications (Rexach et al., 2012; Rexach et al., 2010). In
previous work, neurons were activated by KCl-induced depolarization and, at defined time
points, the cell lysates were mass tagged and immunoblotted with both a total CREB
antibody and a phospho-Ser133-specific CREB antibody. This enabled us to visualize 4
distinct posttranslationally-modified subpopulations of CREB and probe how glycosylation
affected the kinetics of CREB phosphorylation and vice versa (Rexach et al., 2012).
Basic Protocol I: Labeling O-GlcNAc residues in cell lysates with a
resolvable mass tag using oxime chemistry
Materials
Sodium dodecyl sulfate (SDS)
Complete Protease Inhibitor Tablet (Roche); dissolve to 50X concentration in 1 mL of
H2O
Protein concentration assay, such as the bicinchoninic acid (BCA) protein detection
assay
Methanol
Chloroform
H2O (Ultrapure or Milli-Q grade)
Triton X-100 (20% w/v in H2O)
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) (100 mM, pH 7.9)
100 mM MnCl2
5 M NaCl
UDP-ketogalactose (Uridine 5′-diphospho-2-acetonyl-2-deoxy-α-D-galactopyranose
diammonium salt; synthesis described in (Khidekel et al., 2003))
Mutant Y289L galactosyltransferase (Y289L GalT; 2 mg/mL; (Khidekel et al., 2003);
see Support Protocol I)
Urea (ultra pure)
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3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)
Dithiothreitol (DTT)
Aminooxy-functionalized poly(ethylene glycol) (aminooxy-functionalized PEG; 60 mM
in H2O; synthesis described in (Rexach et al., 2010))
Sodium acetate buffer (1.8 M, pH 3.89)
pH indicator paper (pH 1–6)
Protocol
Lysing the cells or tissue pellet and measuring protein concentration
1 Prepare a cell or tissue pellet using standard techniques. Lyse it by adding an
equal volume of boiling Lysis Buffer (2% SDS (w/v) in H2O, 1X Roche
Complete Protease Inhibitor Cocktail; see Reagents and Solutions) to resuspend
the sample.
Lysing the cell or tissue sample quickly under denaturing conditions is
critical to maintain the protein glycosylation states. In those cases
where non-denaturing buffers will be used, prepare the sample on ice
using ice-cold buffers and supplement each buffer with a β-N-
acetylglucosaminidase inhibitor such PUGNAc (O-(2-acetamindo-2-
deoxy-D-glucopyranosylidene)amino N-phenylcarbamate, 10 μM) and
the phosphatase inhibitors NaVO3 (1 mM), NaF (20 mM), and
Na2MoO4 (0.5 mM). Occasionally it may be desirable or advantageous
to perform a subcellular fractionation (see Troubleshooting).
2 Sonicate the cell lysate until the solution is no longer viscous.
3 Boil the sample for 5 minutes.
4 Centrifuge the sample for 10 minutes at 21,885 x g, 4 °C. Promptly remove the
sample from the centrifuge and place at room temperature to avoid SDS
precipitation. Transfer the solubilized lysate in the supernatant into a fresh 1.5-
mL microcentrifuge tube and discard any remaining pellet.
5 Measure the protein concentration of your sample.
We generally prefer measuring protein concentrations using the BCA
protein detection assay due to its compatibility with high
concentrations of SDS. However, other protein detection assays that are
compatible with the chosen lysis buffer may also be acceptable.
Precipitating the protein
6 Aliquot 100 μg of protein into a 1.5-mL microcentrifuge tube. If the volume of
the 100 μg protein solution is less than 100 μL, add Lysis Buffer to 100 μL. If
the volume of the 100 μg protein solution is greater than 100 μL, then scale the
volume of the following solutions accordingly.
For each set of experimental conditions, it is important to also prepare a
separate control sample that will be incubated with everything except
for the Y289L GalT enzyme.
7 To the 100 μL of protein lysate, add 300 μL of methanol, and vortex the
solution. Next, add 100 μL of chloroform, and vortex the solution again. Finally,
Clark et al. Page 3
Curr Protoc Chem Biol. Author manuscript; available in PMC 2014 December 01.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
add 225 μL of water and vortex. Each vortex step should be carried out for
approximately 10 seconds.
The solution should quickly separate into two phases, with a clear
bottom phase and a cloudy top phase.
8 Centrifuge the samples for 10 minutes at 21,885 x g, 4 °C.
Two separate phases should appear after centrifuging the samples and a
white pellet (the precipitated protein) should reside at the interface of
those phases.
9 Immediately remove and discard most of the top phase without disturbing the
pellet.
The top layer can usually be removed down to within a millimeter or
two of the pellet without disturbing it. These steps should be done at
room temperature.
10 Add 225 μL of methanol and gently disrupt the protein pellet by briefly
vortexing or inverting the tube several times until the top and bottom phases are
fully mixed.
Be careful not to lose your pellet in the tube cap at this step.
11 Centrifuge the sample for 10 minutes at 21,885 x g, 4 °C.
After centrifuging the sample, the solution should be in only one phase
and the white pellet should now reside at the bottom of the tube.
12 Remove the liquid phase and allow the pellet to air dry.
It is important that the solution phase fully evaporates without over-
drying the pellet. Over or under-dried pellets will be difficult to
resuspend. An ideal point is typically when the pellet is still somewhat
translucent and no liquid puddle remains. If all of the supernatant has
been carefully removed from the pellet, the pellet will usually dry
within 30 minutes.
Labeling the samples with ketogalactose and mutant Y289L
galactosyltransferase
13 Resuspend the pellet in 20 μL of Ketone Labeling Resuspension Buffer (1%
SDS (w/v) in H2O, 1X Roche Complete Protease Inhibitor Cocktail; see
Reagents and Solutions).
Resuspending the protein sample after precipitation is often difficult,
particularly if it is over or under dry. Vortexing the sample (being
careful not to cause foam), sonicating the sample, boiling the sample,
and agitating the sample by pipetting may all improve the speed and
efficiency of protein resuspension.
14 To each sample, place the 20 μL of resuspended protein (5 mg/mL) on ice and
add in the following order: 9 μL of 20% Triton X-100, 38 μL of H2O, 10 μL of
100 mM HEPES pH 7.9, 10 μL of 100 mM MnCl2, 2 μL of 5 M NaCl, 2 μL of
50X Roche Complete Protease Inhibitor Cocktail. Mix by pipetting up and
down. Then add 5 μL of 10 mM UDP-ketogalactose substrate and mix. To all
samples except the control reaction, add 4 μL of 2 mg/mL Y289L GalT. To the
control reaction, add 4 μL of H2O.
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In those situations where a significant number of samples will be
labeled, a master mix containing H2O, HEPES, MnCl2, NaCl, and
protease inhibitor cocktail can be prepared. In that case, add the Triton
X-100 to the sample and pipette to fully mix, followed by the master
mix, UDP-ketogalactose, and Y289L GalT (in that order).
The addition of 4 μL of 2 mg/mL Y289L assumes that the Y289L GalT
is sufficiently active to completely label a model glycosylated peptide
at a concentration of 50 ng/μL (see Support Protocol I). If the Y289L
GalT is less active, then adjust the enzyme concentration to ensure
complete reaction.
15 Incubate the reaction overnight (12 – 16 hours) at 4 °C while inverting the
sample end-over-end.
16 Precipitate the protein as described above (‘Precipitating the protein’).
Labeling the samples with the aminooxy-functionalized PEG mass tag
17 Resuspend the precipitated protein in 43.6 μL of Mass Tag Resuspension Buffer
(7 M urea, 10 mM HEPES, pH 7.9, 2% (w/v) CHAPS, 1 mM DTT, 1X Roche
Complete Protease Inhibitor Cocktail; see Reagents and Solutions).
As before, this step is often difficult if the pellet is not ideally dried. It
may take up to an hour for the precipitated protein to redissolve.
18 Add 6 μL of 60 mM aminooxy-functionalized PEG, 1.422 μL of 1.8 M sodium
acetate buffer, pH 3.89, and mix.
The aminooxy reaction requires a pH of 4.5. Check the final pH of your
solution on pH paper to ensure that it is 4.5.
19 Incubate at room temperature for 20–24 hours. Gently rock the samples by
placing them in a tube rack on a table-top rocker.
20 After the 20–24 hour incubation, add 50 μL of Neutralization Buffer (1% (w/v)
SDS, 100 mM HEPES, pH 7.9; see Reagents and Solutions), mix, and
precipitate the reaction as described above (‘Precipitating the protein’).
21 Resuspend the pellet in 30 μL of 1% (w/v) SDS to a final concentration of 3.3
mg/mL. Perform gel electrophoresis and immunoblotting using standard
techniques. During initial experiments, we typically run the entire sample in a
single gel lane.
Best results are generally achieved by resolving 50–75% of the labeled
protein dissolved in SDS-PAGE loading dye on a 4–12% Bis-Tris
NuPAGE gradient gel (Invitrogen). To adequately resolve the shifted
from the non-shifted protein subpopulations, the gel is typically run
until the protein of interest has migrated through at least 50% of the
gel.
As Nup62 and Sp1 are heavily O-GlcNAc glycosylated, they serve as
excellent positive controls for the labeling experiments (Fig. 1).
See Data Analysis for how to calculate protein glycosylation
stoichiometries.
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Basic Protocol II: Labeling O-GlcNAc residues in cell lysates with a
resolvable mass tag using [3+2] azide-alkyne cycloaddition chemistry
Basic Protocol I describes labeling O-GlcNAc residues in cell lysates with a resolvable mass
tag by reacting a ketone moiety with an aminooxy PEG reagent to form an oxime linkage.
This is the best-characterized system but requires chemical synthesis of the UDP-
ketogalactose and aminooxy-functionalized PEG reagents. An alternative to this approach
relies on [3+2] azide-alkyne cycloaddition (“Click”) chemistry, which can be performed
with commercially available materials (Scheme 1b). The “Click” protocol utilizes a Click-iT
O-GlcNAc Enzymatic Labeling System (Invitrogen) for the first set of reactions, and a
Click-iT Protein Reaction Buffer Kit (Invitrogen) and alkynyl-functionalized PEG (Creative
PEGWorks) for the second set of reactions. While both methods apply the same principles,
it is important to note that the “Click” protocol may require some validation. For example, it
is essential to confirm that the cycloaddition reaction proceeds to completion under your
conditions.
Materials
Sodium dodecyl sulfate (SDS)
Complete Protease Inhibitor Tablet (Roche); dissolve to 50X concentration in 1 mL of
H2O
Complete Protease Inhibitor Tablet EDTA-free (Roche); dissolve to 50X concentration
in 1 mL of H2O
Protein concentration assay, such as the bicinchoninic acid (BCA) protein detection
assay
Methanol
Chloroform
H2O (Ultrapure or Milli-Q grade)
Click-iT O-GlcNAc Enzymatic Labeling System (Invitrogen)
Dimethylsulfoxide (DMSO)
Click-iT Protein Reaction Buffer Kit (Invitrogen)
Alkynyl-functionalized poly(ethylene glycol) (alkynyl-functionalized PEG; mPEG-
Alkyne, 2-kDa or 5-kDa, Creative PEGWorks; 10 mM in DMSO)
Before using any new batch of PEG, it is important to check the quality by
mass spectrometry. The spectrum of high quality PEG has one peak centered
on the correct mass (2-kDa or 5-kDa). The spectrum of low quality PEG has
multiple peaks, usually centered at intervals of the correct mass.
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) (100 mM, pH 7.9)
Protocol
Follow Steps 1 – 12 of Basic Protocol I.
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Labeling the samples with azidogalactose and mutant Y289L
galactosyltransferase (modified from the ‘Click-iT O-GlcNAc Enzymatic
Labeling System’ manual)
13 Resuspend the pellet in 20 μL of Azide Labeling Resuspension Buffer (1% SDS
(w/v) in 20 mM HEPES pH 7.9, 1X Roche Complete Protease Inhibitor
Cocktail; see Reagents and Solutions).
Resuspending the protein sample after precipitation is often difficult,
particularly if it is over or under dry. Vortexing the sample (being
careful not to cause foam), sonicating the sample, boiling the sample,
and agitating the sample by pipeting may all improve the speed and
efficiency of protein resuspension.
14 Add 144 μL of 10 mM HEPES buffer, pH 7.9 to the UDP-GalNAz (Component
A of the ‘Click-iT O-GlcNAc Enzymatic Labeling System’) and mix well.
Keep on ice. Aliquot any remaining UDP-GalNAz and store at −80 °C
until further use.
15 For each resuspended protein sample (Step 13), place the 20 μL of resuspended
protein on ice and add, in the following order: 22.5 μL of H2O, 40 μL of
Labeling buffer (Component C of the ‘Click-iT O-GlcNAc Enzymatic Labeling
System’), 5.5 μL of 100 mM MnCl2, and 2 μL of 50X Roche Complete Protease
Inhibitor Cocktail. Mix by pipetting up and down. Then add 5 μL of 0.5 mM
UDP-GalNAz and mix. Finally, to each sample except the control reaction, add
5 μL of Y289L GalT (labeled as Gal-T1 (Y289L), Component B of the ‘Click-
iT O-GlcNAc Enzymatic Labeling System’). To the control reaction, add 5 μL
of H2O.
16 Incubate the reaction overnight (12 – 16 hours) at 4 °C while inverting the
sample end-over-end.
17 Precipitate the protein as described above (‘Precipitating the protein’).
Labeling the samples with the alkynyl-functionalized PEG mass tag (modified
from the ‘Click-iT Protein Reaction Buffer Kit’ manual)
18 Resuspend the precipitated protein in 25 μL of Alkynyl Labeling Resuspension
Buffer (1% SDS (w/v) in 50 mM Tris-HCl, pH 7.5, 1X Roche Complete
Protease Inhibitor Cocktail EDTA free; see Reagents and Solutions).
As before, this step is often difficult. It may take up to an hour for the
precipitated protein to redissolve.
19 Add the alkynyl-functionalized PEG (10 mM) to the Click-iT reaction buffer
(Component A of the ‘Click-iT Protein Reaction Buffer Kit’) to a final
concentration of 1 mM.
Store any unused reaction buffer at −20 °C for up to a year.
20 Add 500 μL of H2O to Click-iT reaction buffer additive 1 (Component C of the
‘Click-iT Protein Reaction Buffer Kit’) and mix thoroughly.
Store any unused reagent at −20 °C for up to a year. Discard if the
reagent turns brown.
21 Add 540 μL of H2O to Click-iT reaction buffer additive 2 (Component D of the
‘Click-iT Protein Reaction Buffer Kit’) and mix thoroughly.
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Store any unused reagent at 4 °C for up to a year.
22 To the resuspended protein (Step 18), add 50 μL of the alkynyl-poly(ethylene
glycol) in Click-iT reaction buffer (Step 19), 2 μL of 50X Roche Complete
Protease Inhibitor Cocktail EDTA free, and 3 μL of H2O.
23 Vortex for 5 seconds.
24 Add 5 μL of CuSO4. Vortex for 5 seconds.
25 Add 5 μL of Click-iT reaction buffer additive 1 solution (Step 20). Vortex for 5
seconds and wait 3 minutes (but not longer than 5 minutes).
26 Add 10 μL of Click-iT reaction buffer additive 2 (Step 21). Vortex for 5
seconds.
The solution should turn orange at this point.
27 Incubate at room temperature overnight (12 – 16 hours). Gently rock the
samples by placing them in a tube rack on a table-top rocker.
28 After the 20–24 hour incubation, add 50 μL of Neutralization Buffer and
precipitate the reaction as described above (‘Precipitating the protein’).
29 Resuspend the pellet in 30 μL of 1% (w/v) SDS. Perform gel electrophoresis and
immunoblotting using standard techniques. During initial experiments, we
typically run the entire sample in a single gel lane.
Best results are generally achieved by resolving 50–75% of the labeled
protein on a 4–12% Bis-Tris NuPAGE gradient gel (Invitrogen). To
adequately resolve the shifted from the non-shifted protein
subpopulations, the gel is typically run until the protein of interest has
migrated through at least 50% of the gel.
As Nup62 and Sp1 are heavily O-GlcNAc glycosylated, they serve as
excellent positive controls for the labeling experiments.
See Data Analysis for how to calculate protein glycosylation
stoichiometries.
Support Protocol I: Expression and isolation of Y289L GalT
Introduction
Active Y289L GalT can be expressed and isolated from an E. coli expression system
(Ramakrishnan and Qasba, 2002). Upon overexpressing Y289L GalT, E. coli sequester the
protein in inclusion bodies. This protocol describes the isolation and lysis of these inclusion
bodies, followed by refolding of the Y289L GalT protein to its active conformation. Y289L
GalT is also available commercially as part of the Click-iT O-GlcNAc Enzymatic Labeling
System.
Materials
Y289L GalT cDNA in a pET23a plasmid backbone (Ramakrishnan and Qasba, 2002)
2-Nitro-5-(sulfothio)-benzoate (NSTB; must be made fresh as described in
(Thannhauser et al., 1984)).
Ampicillin
Agar bacteria plate containing 100 μg/mL of ampicillin
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Luria-Bentani (LB) broth
Isopropylthio-β-galactoside (IPTG)
Phosphate buffered saline (PBS)
25% (w/v) sucrose in PBS
Guanidine hydrochloride
Sodium sulfite
L-Arginine
Tris-HCl
Ethylenediaminetetraacetic acid (EDTA)
Cysteamine
Cystamine
Dialysis tubing, 10-kDa Nominal Molecular Weight Limit (NMWL)
Centricon centrifugal filter unit, 10-kDa NMWL
Coomassie brilliant blue R-250
Methanol
Acetic acid
SDS-PAGE reagents
MnCl2
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)
UDP-ketogalactose (Uridine 5′-diphospho-2-acetonyl-2-deoxy-α-D-galactopyranose
diammonium salt; synthesis described in (Khidekel et al., 2003))
Click-iT O-GlcNAc Peptide LC/MS standard (Invitrogen)
2,5-dihydroxybenzoic acid
2-hydroxy-5-methoxybenzoic acid
Acetonitrile
Trifluoroacetic acid
Protocol
Inducing protein expression
1 Electroporate BL21(DE3) cells with 0.25 μg of Y289L GalT DNA in a pET23a
plasmid, and plate the bacteria on an agar plate containing 100 μg/mL of
ampicillin. Incubate the plate overnight at 37 °C.
2 Pick three colonies and place each separately into 100 mL of LB broth
containing 100 μg/mL of ampicillin. Incubate the LB broth overnight at 37 °C
with shaking at 235 RPM.
3 Choose the densest colony and dilute it to 1 liter with LB broth containing 100
μg/mL of ampicillin. Incubate the bacteria culture at 37 °C with shaking at 235
RPM. Periodically measure the absorbance of the culture at 600 nm.
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We generally measure the absorbance of the culture every 45 minutes
after diluting with LB.
4 When the absorbance of the culture at 600 nm has reached 0.7 compared to an
LB control, add IPTG to a final concentration of 1 mM. Return the bacteria
culture to 37 °C with shaking at 235 RPM for an additional 4 hours.
5 After the 4 hours, centrifuge the bacteria for 10 minutes at 600 x g, 4 °C.
Discard the supernatant and save the pellet.
After the supernatant has been removed, the bacteria can be frozen at
−20 °C for up to six months.
Isolating the Y289L GalT enzyme
Unless otherwise noted, throughout the GalT isolation and refolding procedure, the
GalT protein is kept on ice.
6 Resuspend the bacteria in 10 mL of ice-cold PBS.
It is important to ensure that all the bacteria have been resuspended
before moving on to the sonication step.
7 Sonicate thoroughly on ice to lyse the bacteria.
The time and intensity of sonication will depend on the type of
sonicator used. We generally sonicate 10 times for 30 seconds at 40%
amplitude with 30 second pauses in between to keep the sample from
heating.
8 Add 70 mL of ice-cold PBS and centrifuge for 30 minutes at 14,000 x g, 4 °C.
Discard the supernatant.
9 Resuspend the pellet in 50 mL of ice-cold 25% (w/v) sucrose in PBS. Centrifuge
for 30 minutes at 14,000 x g, 4 °C.
Resuspending the pellet in this and subsequent steps is often difficult
and laborious. However, it is critical to resuspend the pellet fully at
each step to ensure adequate purity of the Y289L GalT.
10 Repeat Step 9 three more times.
With each subsequent wash, the pellet color should change from the
straw color of LB to a more ivory color.
You can store the pellet after the final wash in 5 mL of 25% (w/v)
sucrose in PBS overnight at 4 °C. Be certain to remove the 25% (w/v)
sucrose in PBS before the next step.
Refolding the Y289L GalT
11 Resuspend the pellet in 20 mL of ice-cold Y289L Resuspension Buffer (5 M
guanidine hydrochloride, 0.3 M sodium sulfite; see Reagents and Solutions).
12 Add 2 mL of NTSB and shake vigorously at room temperature for
approximately 45 minutes.
The NTSB should initially be a pale yellow color. When added to the
solution, the NTSB should turn the solution red. The reaction is
complete when the solution turns from red back to pale yellow. This
usually takes approximately 45 minutes.
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13 Add 180 mL of ice-cold H2O to precipitate the protein and centrifuge the sample
for 10 minutes at 10,000 x g, 4 °C.
14 Discard the supernatant and resuspend the pellet in 10 mL of ice-cold H2O.
Centrifuge the sample for 10 minutes at 10,000 x g, 4 °C.
15 Repeat Step 14 two more times.
16 Resuspend the pellet in 5 M guanidine hydrochloride to a protein concentration
of 1 mg/mL.
1 mg/mL of Y289L GalT has an absorbance of 1.9 to 2.0 at 275 nm.
17 Dilute the protein ten fold in ice-cold Refolding Solution (0.5 M L-arginine, 50
mM Tris-HCl, pH 8.0, 5 mM EDTA, 4 mM cysteamine, 2 mM cystamine; see
Reagents and Solutions) at 4 °C over the course of 15 minutes with slow mixing.
It is important to add the Refolding Solution slowly with shaking. We
usually place the protein solution on an orbital shaker and add 1/15 of
the Refolding Solution each minute over the course of 15 minutes.
Some protein typically precipitates as a white precipitate during the
refolding. The precipitate can be removed by centrifugation (10 min,
10,000 x g, 4 °C) and discarded. Alternatively, the precipitate can be
carried on to Step 18 and removed at Step 19.
18 Dialyze the refolded protein three times for 4 hours with 4 liters of Dialysis
Solution (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 4 mM cysteamine, and 2 mM
cystamine; see Reagents and Solutions) at 4 °C using 10-kDa NMWL dialysis
tubing.
Here again protein will precipitate. Precipitation should not be
interpreted as a failed isolation.
19 Collect the dialyzed solution and centrifuge for 10 minutes at 10,000 x g at 4 °C.
20 Retain the supernatant and concentrate it using a Centricon filter unit with a 10-
kDa cutoff.
We usually concentrate the GalT until it has reached a concentration of
2 mg/mL, which usually requires an approximately 100-fold
concentration.
21 Check the purity of the GalT by performing SDS-PAGE on 7.5 μg of the
concentrated protein and by staining the gel with Coomassie blue stain.
The approximate molecular weight of Y289L GalT is 32-kDa. We
regularly obtain Y289L GalT in high purity (Fig. 2).
22 Check the activity of the Y289L GalT in an O-GlcNAc peptide labeling
reaction. Make up separate 30 μL reactions containing 0, 10, 25, 50, or 100 ng/
μL of Y289L GalT and 5 mM MnCl2, 10 mM HEPES pH 7.9, 1.5 μL of 10 mM
UDP-ketogalactose, and 4 μL of 100 pmole/μL Click-iT O-GlcNAc Peptide LC/
MS Standard. Incubate the reactions overnight at 4 °C.
23 Monitor the addition of the ketogalactose to the O-GlcNAc residue on the
peptide by mass spectrometry analysis (Fig. 3).
We usually analyze the reactions with matrix-assisted laser desorption/
ionization-time of flight (MALDI-TOF) mass spectrometry using a
dihydroxybenzoic acid (DHB) matrix (see Reagents and Solutions),
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although other mass spectrometry methods also work. The unmodified
peptide has a molecular weight of 1118.5 daltons. The ketogalactose
adds 202 daltons to the molecular weight of the peptide. Typically
complete labeling of the peptide occurs using 50 ng/μL of GalT.
Once isolated, the Y289L GalT is stable for approximately one year at
4 °C.
Reagents and Solutions
All reagents and solutions should be prepared with ultrapure (Milli-Q) grade H2O.
Lysis Buffer
2% SDS (w/v) in H2O
1X Roche Complete Protease Inhibitor Cocktail
Once the protease inhibitors have been added, the solution can be stored for up
to 2 weeks at 4 °C. Storage at 4 °C may lead the SDS to precipitate. If this
occurs, be certain to re-dissolve by warming the sample to room temperature
before use.
Ketone Labeling Resuspension Buffer
1% SDS (w/v) in H2O
X Roche Complete Protease Inhibitor Cocktail
Once the protease inhibitors have been added, the solution can be stored for up
to 2 weeks at 4 °C. Storage at 4 °C may lead the SDS to precipitate. If this
occurs, be certain to re-dissolve by warming the sample to room temperature
before use.
Mass Tag Resuspension Buffer
7 M Urea (ultra pure)
10 mM HEPES, pH 7.9
2% (w/v) CHAPS
1 mM DTT
1X Roche Complete Protease Inhibitor Cocktail
This solution should be prepared fresh each time.
Freshly dissolved, ultrapure urea is critical in this step. A urea breakdown
product is isocyanate, which may inhibit the aminooxy reaction and which is
found as an impurity in urea preparations.
Neutralization Buffer
1% (w/v) SDS
100 mM HEPES, pH 7.9
Azide Labeling Resuspension Buffer
1% SDS (w/v) in 20 mM HEPES pH 7.9
1X Roche Complete Protease Inhibitor Cocktail
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Once the protease inhibitors have been added, the solution can be stored for up
to 2 weeks at 4 °C. Storage at 4 °C may lead to precipitation of the SDS. If this
occurs, be certain to re-dissolve it by warming the buffer to room temperature
before use.
Alkynyl Labeling Resuspension Buffer
1% SDS (w/v) in 50 mM Tris-HCl, pH 7.5
1X Roche Complete Protease Inhibitor Cocktail EDTA free
Once the protease inhibitors have been added, the solution can be stored for up
to 2 weeks at 4 °C. Storage at 4 °C may lead to precipitation of the SDS. If this
occurs, be certain to re-dissolve it by warming the buffer to room temperature
before use.
Y289L Resuspension Buffer
5 M Guanidine hydrochloride
0.3 M Sodium sulfite
Refolding Solution
0.5 M L-Arginine
50 mM Tris-HCl, pH 8.0
5 mM EDTA
4 mM Cysteamine
2 mM Cystamine
Dialysis Solution
50 mM Tris-HCl, pH 8.0
5 mM EDTA
4 mM Cysteamine
2 mM Cystamine
Coomassie Brilliant Blue Stain
0.1% (w/v) Coomassie brilliant blue R-250
50% (v/v) MeOH
7.5% (v/v) Acetic acid
42.5% H2O
DHB matrix
1. Prepare a 20 mg/mL solution of 2,5-dihydroxybenzoic acid in an 80% acetonitrile
solution containing 0.1% trifluoroacetic acid.
2. Prepare a 20 mg/mL solution of 2-hydroxy-5-methoxybenzoic acid in an 80%
acetonitrile solution containing 0.1% trifluoroacetic acid.
3. Prepare a 9:1 mixture of the 2,5-dihydroxybenzoic acid solution (Step 1) and the 2-
hydroxy-5-methoxybenzoic acid solution (Step 2).
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Background
Selective and quantitative labeling of O-GlcNAc residues with the poly(ethylene glycol)
mass tag is key to measuring O-GlcNAc stoichiometries using this chemoenzymatic
approach. Previous studies have shown that GalT demonstrates greater than 11-fold
selectivity for N-acetylglucosamine over glucose and glucosamine (Ramakrishnan and
Qasba, 2002). The unnatural UDP-ketogalactose sugar is a selective substrate for the Y289L
GalT mutant and is a poor substrate for endogenous GalT (Khidekel et al., 2003). Thus, the
enzymatic labeling step allows for selective labeling of O-GlcNAc residues only in those
reactions in which both the Y289L GalT and UDP-ketogalactose sugar have been included.
Moreover, the oxime formation reaction between aminooxy and ketone groups is considered
bioorthogonal as ketones and aldehydes are generally not found on proteins. At pH 4.5, only
those proteins labeled with the unnatural ketogalactose sugar will be further elaborated with
the aminooxy-functionalized PEG tag. Finally and most importantly, both the GalT reaction
and subsequent oxime formation reaction proceed quantitatively. The mutant GalT
quantitatively labels a model O-GlcNAcylated peptide within 6 hours at 4 °C (Khidekel et
al., 2003), and the aminooxy reaction goes to completion on model peptides and proteins
within 20 hours at room temperature (Khidekel et al., 2003; Rexach et al., 2010). The
quantitative yield for each reaction is critical to ensure accurate calculation of glycosylation
stoichiometries.
Most other methods for O-GlcNAc detection focus on relative changes in O-GlcNAc levels,
rather than absolute values (Zachara, 2009). In contrast, the mass tagging approach allows
for direct measurement of in vivo O-GlcNAc stoichiometries. This enables a more
comprehensive analysis of the role of O-GlcNAc glycosylation in specific protein contexts.
For example, we found that glucosamine stimulation of rat embryonic neurons induced a
1.4- and 3.1-fold increase in O-GlcNAcylation of CREB and Golgi reassembly-stacking
protein of 55-kDa (GRASP55), respectively, suggesting that GRASP55 might be more
responsive than CREB to glucosamine. However, further examination using the mass
tagging approach revealed that both proteins underwent a similar change in glycosylation
stoichiometry (13.1 ± 0.2% and 10.2 ± 0.5%, respectively), suggesting instead that
glucosamine may uniformly induce OGT activity toward these substrates (Rexach et al.,
2010). In another example, the mass tagging approach revealed that CREB is predominantly
monoglycosylated in neurons despite having at least 3 distinct glycosylation sites. By
combining the approach with site-directed mutagenesis, we found that CREB is glycosylated
primarily at a single site, Ser40, and that glycosylation is induced by neuronal activity
specifically at this site (Fig. 4) (Rexach et al., 2012). Thus, the mass-tagging approach
provides a direct readout of the glycosylation state and stoichiometry, and when applied in
conjunction with site-directed mutagenesis, it has the power to reveal the sugar occupancy at
specific glycosylation sites. In contrast, mass spectrometry methods are valuable for
identifying the O-GlcNAc sites, but they cannot readily determine their relative occupancy
or interrelationship within the same molecule. This highlights the complementary
information obtained using the mass tagging approach and mass spectrometric analyses.
Knowing the glycosylation stoichiometry of a protein may provide evidence of the
modification’s significance or may suggest how best to study it. For example, if the
stoichiometry is low, glycosylation may be inducible, and further tests can be performed to
examine the glycosylation dynamics in response to cellular stimuli. It is also worth noting
that the same chemoenzymatic strategy can be used to attach other reporter groups, such as a
biotin moiety. The biotin handle provides a sensitive method for the enrichment and
detection of O-GlcNAcylated peptides/proteins (Tai et al., 2004), and it can facilitate the
identification of O-GlcNAc modification sites by mass spectrometry (Khidekel et al., 2007;
Khidekel et al., 2004).
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In addition to quantifying glycosylation stoichiometries, the mass tagging approach can
provide insights into the complex interplay between O-GlcNAc and other posttranslational
modifications. By immunoblotting the mass-tagged lysate with both a phospho-specific
antibody and an antibody against the total protein, four different subpopulations are
resolved: the (1) non-glycosylated, (2) glycosylated, (3) phosphorylated, non-glycosylated,
and (4) simultaneously phosphorylated and glycosylated forms (Fig. 5). This provides a
direct readout of whether the two modifications are mutually exclusive on proteins of
interest or whether they can coexist on the same molecule. The strategy also enables
dynamic changes in glycosylation to be monitored specifically on the phosphorylated
subpopulation and vice versa. For example, we determined that phosphorylation precedes
glycosylation of CREB in response to KCl-induced neuronal depolarization (Rexach et al.,
2012). In other studies, traditional O-GlcNAc detection methods showed that total O-
GlcNAcylation levels increase on the transcriptional repressor methyl-CpG-binding protein
2 (MeCP2) in response to glucosamine (GlcN), while total Ser80 phosphorylation levels
decrease, suggestive of an opposing, yin-yang relationship between glycosylation and
phosphorylation. However, closer inspection using the mass tagging approach revealed that
glycosylation was induced preferentially on the Ser80 phosphorylated subpopulation of
MeCP2. Moreover, despite overall decreases in Ser80 phosphorylation in response to GlcN,
Ser80 phosphorylation increased specifically on the glycosylated MeCP2 subpopulation.
These results suggest instead a reverse yin-yang relationship and highlight the complex,
potentially synergistic relationship between glycosylation and phosphorylation on MeCP2
(Rexach et al., 2010).
Critical Parameters and Considerations
The main choice to be made during this protocol is whether to use a 2-kDa or 5-kDa PEG
mass tag in Step 2. The selection depends on the size of the protein of interest. In our
experience, proteins smaller than 50-kDa are better visualized using a 2-kDa mass tag,
whereas proteins larger than 50-kDa are better visualized using a 5-kDa mass tag.
Glycosylation of the 110-kDa subunit of O-GlcNAc transferase (OGT) was readily
visualized with a 5-kDa mass tag, while a 2-kDa mass tag was used for the 43-kDa protein
CREB (Rexach et al., 2010). Although our studies have focused on proteins within this
molecular weight range (40–110-kDa), the mass tagging approach should be amenable in
principle to proteins outside of this range.
Different antibodies display different background signals. Additionally, the mass tag could
limit antibody recognition of the protein, although we have never directly encountered this
situation. For initial experiments, we recommend immunoblotting mass tag-labeled lysate
with at least two independent antibodies for the protein of interest to ensure minimal
background and adequate detection of the mass tag-labeled samples (Fig. 6).
Good positive control proteins for this reaction include specificity protein 1 (Sp1) and
nucleoporin 62-kDa (Nup62). Sp1 from 293T cells and Nup62 from adult rat brain are 100%
glycosylated and should resolve as a ladder of 4 and 8 shifted bands, respectively (Fig. 1).
Appropriate antibodies to detect these proteins include Millipore 07-645 for Sp1 and BD
Biosciences 610497 for Nup62. An incomplete shift in Sp1 and Nup62 would suggest that
the labeling reaction did not go to completion. If this is the case, longer protein transfer
times, longer incubation times, or more enzyme and substrate may be required (see
Troubleshooting).
Chemoenzymatic labeling with mass tags is a quantitative approach for measuring the O-
GlcNAcylation stoichiometry on a protein. In our experience, many proteins are O-
GlcNAcylated at low stoichiometry (<10%). We have been able to detect as little as 0.8% of
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a glycosylated OGT standard and 2.3% of endogenous glycosylated synapsin from the adult
rat brain cortex, highlighting the sensitivity of the mass tagging approach (Figs. 1 and 7). As
traditional enhanced chemiluminescence (ECL)-based methods provide a limited linear
detection range, we recommend analyzing the immunoblots using a more quantitative
detection method, such as the Odyssey Western Blot detection system.
We developed the mass tagging approach to measure the stoichiometry of intracellular O-
GlcNAc glycosylation. The method works by selectively labeling terminal GlcNAc residues.
Terminal GlcNAc residues are characteristic of intracellular O-GlcNAc glycosylation but
may also be found on complex extracellular glycans. In most cases, proteins are known to be
intracellular or extracellular, making it easy to determine whether the terminal GlcNAc
comprises the intracellular O-GlcNAc modification or a larger extracellular glycan.
However, proteins with extracellular O-GlcNAc glycosylation have recently been identified
(Matsuura et al., 2008). In those cases where the assignment is less clear, additional methods
such as subcellular fractionation or mass spectrometry may be required to carefully
characterize the type of glycosylation. For example, chemoenzymatic labeling of O-
GlcNAc-modified proteins with a biotin tag provides a unique signature upon MS/MS
analysis that allows for unambiguous assignment of the O-GlcNAc modification (Khidekel
et al., 2004).
We have studied the [3+2] azide-alkyne cycloaddition labeling method in less detail than the
ketone-aminoxy oxime labeling method. The Y289L GalT/UDP-GalNAz step goes to
completion on a model peptide within 12 hours at 4 °C. When using this approach, it will be
important to determine conditions that lead to complete reaction between the azido-galactose
labeled proteins and alkynyl-functionalized PEG. O-GlcNAcylation stoichiometries should
be interpreted carefully until the approach is fully validated with proteins of known
stoichiometry (Rexach et al., 2010).
Anticipated Results
Chemoenzymatic labeling with mass tags can provide information on the O-GlcNAc
modification state of a protein (e.g. whether the protein is predominantly mono-, di-, or
triglycosylated), as well as its in vivo glycosylation stoichiometry. The expected result from
a successful labeling reaction is an immunoblot containing a negative control lane (e.g., no
GalT added) with a band for the protein of interest and an experimental lane containing this
band shifted (either entirely or in part) by 2- or 5-kDa mass increments, depending on the
mass tag used (Fig. 1).
Data Analysis
The number of extra bands in the experimental lane represents the different glycosylated
subpopulations of the protein. A single band shifted higher by 2- or 5-kDa suggests that the
protein is predominantly monoglycosylated. The presence of two bands, one shifted higher
by 2- or 5-kDa and the other by 4- or 10-kDa, suggests that the protein is both mono- and
diglycosylated. It is important to note that although a protein may be monoglycosylated, it
can still have multiple sites of glycosylation. The number of mass-shifted bands only
describes the distinct glycosylated subpopulations that have a total of one, two, three, etc. O-
GlcNAc sugars per protein. As such, the monoglycosylated subpopulation may consist of
multiple different glycoforms, as in the case of CREB (Rexach et al., 2012).
O-GlcNAcylation stoichiometries must be carefully calculated to obtain accurate,
reproducible results. To determine the stoichiometry of a specific glycosylated
subpopulation, the ratio of the intensity of that mass-shifted band to the intensity of all the
protein bands (shifted and non-shifted) is taken, accounting for background signal in the
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control lane. Specifically, in the experimental lane, the intensity of the non-shifted band (en)
and each mass-shifted band should be individually quantified (es1, es2, …). In the control
lane, the intensity of the background signal corresponding to each of the mass-shifted bands
should be individually quantified (cs1, cs2, …). The following formula can then be used to
calculate the total protein glycosylation stoichiometry:
Alternatively, the glycosylation stoichiometry of a specific glycosylated subpopulation si
can be calculated as:
When quantifying immunoblots, care should be taken to use a quantitative immunoblotting
system (e.g. an Odyssey system) or ECL film exposures in which the intensity of each band
is within the linear range.
Time considerations
The entire labeling experiment can be completed in two to three days. Both the
ketogalactose labeling step and the aminooxy PEG labeling steps require approximately 90
minutes of hands-on time. Cell lysis, protein concentration measurements, SDS-PAGE, and
immunoblotting procedures can take variable amounts of hands-on time, depending on
individual approaches to each step.
Troubleshooting
Problem Possible Cause Solution
No mass tag shift is detected
even though other O-GlcNAc
detection methods suggest that
the protein is glycosylated,
and a control O-GlcNAc
protein (e.g. Nup62 or Sp1) in
the lysate is showing the
anticipated mass shift.
The protein glycosylation
stoichiometry level is below the
detection limit of the antibody.
Increase the amount of the protein of interest
on the SDS-PAGE gel, either by labeling a
greater amount of lysate or by enriching for the
protein through subcellular fractionation or
immunoprecipitation.
No or low levels of
glycosylation are detected on
positive control proteins (e.g.
Nup62 or Sp1), despite
verified reagents and good
quality sample.
The mass-tagged proteins are
difficult to transfer to the
immnoblotting membrane and
have failed to fully transfer.
Increase the transfer time by 33%.
The labeling reaction did not
proceed quantitatively.
Increase enzyme and substrate concentrations
and/or reaction times.
The glycosylated protein
fraction was not adequately
separated from the non-
glycosylated protein fraction.
The protein was not sufficiently
resolved.
Run the protein of interest further through the
gel to allow for adequate subpopulation
separation. Consider a gradient gel or altering
the acrylamide percentage.
The size of the mass tag chosen
was too small.
Choose a larger size mass tag (e.g. 5-kDa
instead of 2-kDa). We usually use a 2-kDa
PEG mass tag for proteins smaller than 50-kDa
and a 5-kDa PEG mass tag for proteins larger
than 50-kDa.
Multiple bands are seen in
both the control and
The antibody chosen for analyzing
the protein of interest identifies
Immunoblot with a different antibody against
the protein of interest.
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Problem Possible Cause Solution
experimental lanes of the
immunoblot.
multiple proteins and is obscuring
the mass shift.
The protein is modified by other
post-translational modifications
(i.e. ubiquitinylation) that cause a
shift in the protein’s apparent
molecular weight.
Pre-treat the samples to remove these other
post-translational modifications.
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Figure 1.
O-GlcNAc stoichiometries of Sp1, Nup62, synapsin IIa, and CREB. Cell lysates were
labeled with the unnatural ketogalactose sugar (1), reacted with a 2-kDa or 5-kDa mass tag
(2), resolved by SDS-PAGE, and identified by immunoblotting. A 2-kDa mass tag was used
to label CREB and a 5-kDa mass tag was used to label Sp1, Nup62, and synapsin Ia (upper
band) and synapsin IIa (lower band). (…) denotes the non-glycosylated protein fraction; (←)
denotes shifted protein fraction.
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Figure 2.
Y289L GalT. 0.75, 1.5, and 7.5 μg of expressed and refolded Y289L GalT was resolved on
a 4–12% Bis-Tris NuPAGE gel and stained with Coomassie brilliant blue.
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Figure 3.
Mass spectrometry analysis of the ketogalactose labeling of an O-GlcNAc glycosylated
peptide. (a) Control reaction (no GalT). The unlabeled peptide has a molecular weight of
1118.4 daltons. (b) Labeling reaction. The product of the ketogalactose labeling has a
molecular weight of 1320.5 daltons. The presence of unlabeled peptide at m/z 1118.4
suggests that the reaction did not go to completion and that a higher concentration of GalT
should be used for labeling reactions.
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Figure 4.
The mass tagging approach was used to determine that CREB is primarily glycosylated at
Ser40 and that glycosylation is specifically induced by neuronal depolarization with KCl at
Ser40. Neurons were electroporated with wild-type (WT) or mutant CREB constructs, in
which the 6 potential glycosylation sites were mutated in various combinations. Neurons
were then depolarized with 55 mM KCl, as indicated for 2 hours. Cell lysates were labeled
with the mass tagging approach and visualized by immunoblotting for Flag-tagged CREB.
Error bars, mean ± s.e.m. * P < 0.01 compared to WT, -KCl; ** P < 0.05; NS, not
significant.
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Figure 5.
The mass tagging approach can be used to identify different posttranslationally-modified
protein subpopulations. Cell lysates were labeled with the mass tagging approach, resolved
by SDS-PAGE, and immunoblotted with an antibody against CREB or Ser133
phosphorylated CREB.
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Figure 6.
Immunoblotting with at least two independent antibodies for a specific protein helps confirm
that the mass tag does not affect antibody recognition. In this example, cell lysate was
labeled using the mass tagging approach, resolved by SDS-PAGE, and immunoblotted with
two different antibodies against O-GlcNAc transferase (OGT).
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Figure 7.
The mass tagging approach can detect as little as 0.8% of glycosylated OGT. Labeled and
unlabeled cell lysate was combined to mimic different OGT glycosylation stoichiometries.
The limit of detection was determined as the lowest stoichiometry within 10% of the linear
fit.
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Scheme 1.
Chemoenzymatic labeling of O-GlcNAc residue with mass tags. (a) O-GlcNAcylated
proteins in cell lysates are labeled with an unnatural ketogalactose sugar (1) and a mutant
galactosyltransferase (Y289L GalT). Labeled proteins are reacted with an aminooxy-
functionalized 2-kDa or 5-kDa mass tag (2) through a bioorthogonal oxime forming
reaction. Glycosylated proteins labeled with the mass tag are resolved and identified by
immunoblotting. The mass tag shifts the mass of the glycosylated subpopulation by intervals
of 2-kDa or 5-kDa, depending on the number of O-GlcNAc moieties attached. (b)
Alternatively, O-GlcNAcylated proteins in cell lysates are labeled with an unnatural
azidogalactose sugar (3) and the mutant GalT. Labeled proteins are reacted with an alkynyl-
functionalized 2-kDa or 5-kDa mass tag (4) through a bioorthogonal [3+2] azide-alkyne
cycloaddition chemistry reaction.
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